Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Emily Hong
First-In-Human Trial of 64Cu-Sartate PET Imaging of Patients With Neuroendocrine Tumours Demonstrates High Tumor Uptake and Retention, Potentially Allowing Prospective Dosimetry for Peptide Receptor Radionuclide Therapy
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Related publications
Joint Guidance on Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumors
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Three-Dimensional Radiobiological Dosimetry of Kidneys for Treatment Planning in Peptide Receptor Radionuclide Therapy
Medical Physics
Medicine
Nuclear Medicine
Radiology
Imaging
Biophysics
PET Imaging of VEGFR With a Novel 64Cu-Labeled Peptide
ACS Omega
Chemistry
Chemical Engineering
Peptide Receptor Radionuclide Therapy
Best Practice and Research in Clinical Gastroenterology
Gastroenterology
Peptide Receptor Radionuclide Therapy
Predictors of Long-Term Outcome in Patients With Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors After Peptide Receptor Radionuclide Therapy With 177Lu-Octreotate
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Peptide Receptor Radionuclide Therapy Plus Somatostatin Analogues for a Neuroendocrine Tumour Combined and Maintenance Treatment
Clinical and Translational Imaging
Nuclear Medicine
Radiology
Imaging
68Ga-Dotatate PET/CT for the Early Prediction of Response to Somatostatin Receptor-Mediated Radionuclide Therapy in Patients With Well-Differentiated Neuroendocrine Tumors
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
64Cu-Labeled Phosphonium Cations as PET Radiotracers for Tumor Imaging
Bioconjugate Chemistry
Organic Chemistry
Biotechnology
Pharmacology
Pharmaceutical Science
Bioengineering
Biomedical Engineering
